Bli Banque De Luxembourg Investments Bristol Myers Squibb CO Transaction History
Bli Banque De Luxembourg Investments
- $3.49 Trillion
- Q2 2025
A detailed history of Bli Banque De Luxembourg Investments transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bli Banque De Luxembourg Investments holds 247,000 shares of BMY stock, worth $10.7 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
247,000
Previous 247,000
-0.0%
Holding current value
$10.7 Million
Previous $14.8 Billion
22.65%
% of portfolio
0.33%
Previous 0.45%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,672Shares Held
1.63BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...